ARS Pharmaceuticals, Inc. short interest in 2021
In 2021, ARS Pharmaceuticals, Inc.'s disclosed short interest ran from 9.22% of shares outstanding on 14 May 2021 to 4.49% on 31 Dec 2021, a change of -4.73 percentage points. The year's high was 11.61% on 15 Nov 2021 and its low 4.49% on 31 Dec 2021, averaging 9.11% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 37.21 days on 13 Aug 2021. Full history: ARS Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 9.22% (14 May 2021)
- End of year
- 4.49% (31 Dec 2021)
- Change
- -4.73 pp
- High
- 11.61% (15 Nov 2021)
- Low
- 4.49% (31 Dec 2021)
- Average
- 9.11%
- Highest days to cover
- 37.21 (13 Aug 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 May 2021 | 9.22% | 27.36 | 10-K filed, results (8-K), 10-Q filed, results (8-K) |
| 28 May 2021 | 9.14% | 28.55 | |
| 15 Jun 2021 | 9.50% | 29.11 | |
| 30 Jun 2021 | 9.15% | 21.30 | |
| 15 Jul 2021 | 8.72% | 26.77 | |
| 30 Jul 2021 | 9.21% | 25.24 | |
| 13 Aug 2021 | 9.25% | 37.21 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 9.34% | 12.43 | |
| 15 Sep 2021 | 10.45% | 5.51 | |
| 30 Sep 2021 | 11.49% | 5.38 | |
| 15 Oct 2021 | 11.29% | 7.78 | |
| 29 Oct 2021 | 11.07% | 9.41 | |
| 15 Nov 2021 | 11.61% | 10.77 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 6.29% | 6.27 | |
| 15 Dec 2021 | 5.48% | 3.43 | |
| 31 Dec 2021 | 4.49% | 3.78 |
See also: ARS Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.